Bionano Genomics (BNGO) EBITDA Margin (2017 - 2026)
Bionano Genomics (BNGO) reported EBITDA Margin of 118.09% for Q1 2026, up 1300.0% on a YoY basis from 8.44% in Q1 2025, and down 10.0% sequentially from 107.36% in Q4 2025.
Bionano Genomics (BNGO) EBITDA Margin (2017 - 2026) Analysis & Trends
Bionano Genomics (BNGO) has 10 years of EBITDA Margin data on file, last reported at 118.09% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin rose 1300.0% year-over-year to 118.09%; the trailing twelve-month figure through Mar 2026 stood at 114.03% (up 17168.0% YoY), and the FY2025 full-year result was 116.95%, up 22092.0% from the prior year.
- EBITDA Margin eased to 118.09% in Q1 2026, from 107.36% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 107.36% in Q4 2025 to a low of 1214.98% in Q3 2023.
- A 5-year average of 373.59% and a median of 354.92% in 2024 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin slumped 76977 bps in 2023 and jumped 60699 bps in 2025, its largest moves.
- Tracing BNGO's EBITDA Margin over 5 years: stood at 456.81% in 2022, then jumped by 49 bps to 232.75% in 2023, then soared by 37 bps to 146.28% in 2024, then gained by 27 bps to 107.36% in 2025, then slipped by 10 bps to 118.09% in 2026.
- Business Quant data shows BNGO's EBITDA Margin at 118.09% in Q1 2026, 107.36% in Q4 2025, and 115.9% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 98.77% |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 33.60% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 1.97% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 5.74% |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 34.92% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 20.53% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -2.87% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 4.04% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 13.65% |
| 10 | Bionano Genomics | 4.34 Mn | -9.35 Mn | 3.25 Mn | -118.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -118.09% |
| Dec 31, 2025 | -107.36% |
| Sep 30, 2025 | -115.90% |
| Jun 30, 2025 | -115.85% |
| Mar 31, 2025 | -131.10% |
| Dec 31, 2024 | -146.28% |
| Sep 30, 2024 | -722.89% |
| Jun 30, 2024 | -218.99% |
| Mar 31, 2024 | -354.92% |
| Dec 31, 2023 | -232.75% |
| Sep 30, 2023 | -1,214.98% |
| Jun 30, 2023 | -452.99% |
| Mar 31, 2023 | -510.36% |
| Dec 31, 2022 | -456.81% |
| Sep 30, 2022 | -445.22% |
| Jun 30, 2022 | -480.94% |
| Mar 31, 2022 | -525.68% |
| Dec 31, 2021 | -456.73% |
| Sep 30, 2021 | -444.21% |
| Jun 30, 2021 | -427.28% |